Literature DB >> 17890854

Effects of advanced glycation end product modification on proximal tubule epithelial cell processing of albumin.

Aylin M Ozdemir1, Ulrich Hopfer, Mariana V Rosca, Xing-Jun Fan, Vincent M Monnier, Miriam F Weiss.   

Abstract

AIM: The goal of this work is to understand the cellular effects of advanced glycation end product (AGE)-modified protein on renal proximal tubule cells.
BACKGROUND: A major function of the proximal tubule is to reabsorb and process filtered proteins. Diabetes is characterized by increased quantities of tissue and circulating proteins modified by AGEs. Therefore in diabetes, plasma proteins filtered at the glomerulus and presented to the renal proximal tubule are likely to be highly modified by AGEs.
METHODS: The model system was electrically resistant polarized renal proximal tubular epithelial cells in monolayer culture. The model proteins comprise a well-characterized AGE, methylglyoxal-modified bovine serum albumin (MGO-BSA), and unmodified BSA.
RESULTS: Renal proximal tubular cells handle MGO-BSA and native BSA in markedly disparate ways, including differences in: (1) kinetics of binding, uptake, and intracellular accumulation, (2) processing and fragmentation, and (3) patterns of electrical conductance paralleling temporal changes in binding, uptake and processing.
CONCLUSION: These differences support the idea that abnormal protein processing by the renal tubule can be caused by abnormal proteins, thereby forging a conceptual link between the pathogenic role of AGEs and early changes in tubular function that can lead to hypertrophy and nephropathy in diabetes. (c) 2007 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17890854     DOI: 10.1159/000108757

Source DB:  PubMed          Journal:  Am J Nephrol        ISSN: 0250-8095            Impact factor:   3.754


  11 in total

1.  Glycation-altered proteolysis as a pathobiologic mechanism that links dietary glycemic index, aging, and age-related disease (in nondiabetics).

Authors:  Tomoaki Uchiki; Karen A Weikel; Wangwang Jiao; Fu Shang; Andrea Caceres; Dorota Pawlak; James T Handa; Michael Brownlee; Ram Nagaraj; Allen Taylor
Journal:  Aging Cell       Date:  2011-11-15       Impact factor: 9.304

2.  Effect of advanced glycosylation end products (AGEs) on proliferation of human bone marrow mesenchymal stem cells (MSCs) in vitro.

Authors:  Yi-Qun Lu; Yan Lu; Hui-Juan Li; Xing-Bo Cheng
Journal:  In Vitro Cell Dev Biol Anim       Date:  2012-10-10       Impact factor: 2.416

3.  Mitochondrial complex I defect and increased fatty acid oxidation enhance protein lysine acetylation in the diabetic heart.

Authors:  Edwin J Vazquez; Jessica M Berthiaume; Vasudeva Kamath; Olisaemeka Achike; Elizabeth Buchanan; Monica M Montano; Margaret P Chandler; Masaru Miyagi; Mariana G Rosca
Journal:  Cardiovasc Res       Date:  2015-06-22       Impact factor: 10.787

4.  Elucidation of the etiology and characteristics of pink urine in young healthy subjects.

Authors:  Susumu Ogawa; Junko Takiguchi; Kazuhiro Nako; Masashi Okamura; Takuya Sakamoto; Shigeru Kabayama; Takefumi Mori; Yoshitaka Kinouchi; Sadayoshi Ito
Journal:  Clin Exp Nephrol       Date:  2014-12-05       Impact factor: 2.801

5.  Early urinary markers of diabetic kidney disease: a nested case-control study from the Diabetes Control and Complications Trial (DCCT).

Authors:  Elizabeth F O Kern; Penny Erhard; Wanjie Sun; Saul Genuth; Miriam F Weiss
Journal:  Am J Kidney Dis       Date:  2010-05       Impact factor: 8.860

Review 6.  Advanced Glycation End Products (AGEs) and Chronic Kidney Disease: Does the Modern Diet AGE the Kidney?

Authors:  Amelia K Fotheringham; Linda A Gallo; Danielle J Borg; Josephine M Forbes
Journal:  Nutrients       Date:  2022-06-28       Impact factor: 6.706

7.  Urinary Proteomics Identifies Cathepsin D as a Biomarker of Rapid eGFR Decline in Type 1 Diabetes.

Authors:  Christine P Limonte; Erkka Valo; Viktor Drel; Loki Natarajan; Manjula Darshi; Carol Forsblom; Clark M Henderson; Andrew N Hoofnagle; Wenjun Ju; Matthias Kretzler; Daniel Montemayor; Viji Nair; Robert G Nelson; John F O'Toole; Robert D Toto; Sylvia E Rosas; John Ruzinski; Niina Sandholm; Insa M Schmidt; Tomas Vaisar; Sushrut S Waikar; Jing Zhang; Peter Rossing; Tarunveer S Ahluwalia; Per-Henrik Groop; Subramaniam Pennathur; Janet K Snell-Bergeon; Tina Costacou; Trevor J Orchard; Kumar Sharma; Ian H de Boer
Journal:  Diabetes Care       Date:  2022-06-02       Impact factor: 17.152

Review 8.  Methylglyoxal, obesity, and diabetes.

Authors:  Paulo Matafome; Cristina Sena; Raquel Seiça
Journal:  Endocrine       Date:  2012-09-16       Impact factor: 3.633

9.  Lower urinary pH is useful for predicting renovascular disorder onset in patients with diabetes.

Authors:  Susumu Ogawa; Kazuhiro Nako; Masashi Okamura; Sadayoshi Ito
Journal:  BMJ Open Diabetes Res Care       Date:  2015-06-30

10.  Inhibitory effects and actions of pentacyclic triterpenes upon glycation.

Authors:  Mei-Chin Yin
Journal:  Biomedicine (Taipei)       Date:  2015-08-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.